Latest Genzyme Stories

CARLSBAD, Calif., Oct. 18, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced NASDAQ has halted trading of the Company's common stock. The U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee meets today to review the new drug application (NDA) for KYNAMRO(TM) for the treatment of patients with homozygous familial hypercholesterolemia (FH). The NDA was filed in March 2012 with a standard review of 10 months. The...

CAMBRIDGE, Mass., Oct. 9, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) today announced a two-year agreement with Massachusetts General Hospital (MGH) aimed at furthering translational medicine research to develop new treatments for various types of hematological malignancies and solid tumors. The project-based collaboration unites scientists from MGH and Sanofi, with the goal of maximizing the strengths of both academic and industry cross-organizational expertise, and...

LONDON, September 6, 2012 /PRNewswire/ -- Leading biotech and biopharma organisations are coming together to learn how to maximise their viral security strategies and the new technologies available from the FDA, NIBSC, NIH and a range of industry experts including Genzyme, Baxter and Amgen at the Pathogen Safety Summit this November. Pharma IQ's Pathogen Safety Summit is back for its third year to offer the opportunity to learn and hear insights from key regulatory...

Actors Jason George, Nestor Serrano and Meagan Tandy Will Serve as Celebrity Award Presenters; Henri Termeer, Former President and CEO of Genzyme, Will Receive Lifetime Achievement Award DANA POINT, Calif., Aug. 30, 2012 /PRNewswire-USNewswire/ -- Global Genes | R.A.R.E. Project (www.globalgenes.org) today announced that Faircraft Records/Universal Republic recording artist Chris Mann and singer/songwriter Katrina Parker, both fan favorites and stars of the second season of the NBC...

SOUTH SAN FRANCISCO, Calif. and CAMBRIDGE, Mass., Aug. 29, 2012 /PRNewswire/ -- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma® Gene Expression Classifier to be offered to patients in the state. The companies also announced that Memorial Sloan-Kettering Cancer...

CARLSBAD, Calif., Aug. 6, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today reported pro forma net operating income of $6.2 million for the three months ended June 30, 2012 and a pro forma net operating loss (NOL) of $10.0 million for the six months ended June 30, 2012 compared to a pro forma NOL of $11.6 million and $24.9 million for the same periods in 2011. The significant improvement in the Company's operating results was driven primarily by the $25 million...

NEW YORK, Aug. 2, 2012 /PRNewswire/ -- Five people living with multiple sclerosis (MS) have been selected from nearly 1,200 entries to receive one-on-one support as they set out to overcome a challenge that affects their everyday life. Their journeys will be chronicled as part of Everyday Matters, a first-of-its kind program that draws on practical and scientific applications of positive psychology to engage and inspire those living with or affected by MS. To view the multimedia...

BETHESDA, Md., July 31, 2012 /PRNewswire-USNewswire/ -- The ACMG Foundation for Genetic and Genomic Medicine announced that applications for the prestigious ACMG Foundation/Genzyme Clinical Genetics Fellowship in Biochemical Genetics award Program are now being accepted. For 2012-2013, two awardees will be given the opportunity to participate in an in-depth clinical experience at a premier medical center with expertise and significant clinical volume in the area of biochemical...

NORTHVALE, N.J., July 31, 2012 /PRNewswire/ -- Abon Pharmaceuticals, LLC, a specialty pharmaceutical company, today announced that it has filed an Abbreviated New Drug Application (ANDA), with a paragraph IV certification, with the U.S. Food and Drug Administration (FDA) seeking approval to market its Clofarabine Injection, 1 mg/ml. Abon's Clofarabine Injection is a generic equivalent of Genzyme's CLOLAR® Injection. CLOLAR® injection is a prescription medicine indicated for the...

NEW YORK, July 2, 2012 /PRNewswire/ -- Carl Icahn today issued the following letter to Howard Solomon, Chairman, CEO and President of Forest Laboratories, Inc.: CARL C. ICAHN767 Fifth Avenue, 47th FloorNew York, NY 10153 July 2, 2012 Via Email and Federal ExpressHoward SolomonChairman, CEO and PresidentForest Laboratories, Inc.909 Third AvenueNew York, NY 10022 Your recent statement is rife with inconsistencies, misstatements and doublespeak. I find your statement that we are attempting...